Home Cart Sign in  
Chemical Structure| 143360-00-3 Chemical Structure| 143360-00-3

Structure of SMIP004
CAS No.: 143360-00-3

Chemical Structure| 143360-00-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SMIP004 is an inducer of cancer-cell selective apoptosis of human prostate cancer cells, downregulates SKP2 and stabilizes p27.

Synonyms: SMIP004

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SMIP004

CAS No. :143360-00-3
Formula : C13H19NO
M.W : 205.30
SMILES Code : CC1=C(NC(C)=O)C=CC(CCCC)=C1
Synonyms :
SMIP004
MDL No. :MFCD00277686

Safety of SMIP004

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319-H332-H335
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HeLa cells 40 µM 18 hours No significant increase in p27-luc expression was observed BMC Biol. 2010 Dec 23;8:153
LNCaP prostate cancer cells 40 µM 18 hours SMIP004 increased nuclear p27 levels and downregulated SKP2 expression BMC Biol. 2010 Dec 23;8:153
293T cells 40 µM 24 hours To validate the effect of SMIP004 on SKP2 and PDCD4 expression levels. Results showed that SMIP004 significantly downregulated SKP2 expression levels and upregulated PDCD4 expression levels. J Exp Clin Cancer Res. 2019 Feb 13;38(1):76

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Breast cancer xenograft model Subcutaneous injection 50 mg/kg Twice a week for 2 weeks To validate the inhibitory effect of SMIP004 combined with radiotherapy on breast cancer xenograft models. Results showed that SMIP004 combined with radiotherapy significantly inhibited tumor growth. J Exp Clin Cancer Res. 2019 Feb 13;38(1):76

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.87mL

0.97mL

0.49mL

24.35mL

4.87mL

2.44mL

48.71mL

9.74mL

4.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories